α 2‐Macroglobulin Receptor Mediates Binding and Cytotoxicity of Plant Ribosome‐Inactivating Proteins

European Journal of Biochemistry

Volumn 232, Issue 1, 1995, Pages 165-171

  Cavallaro, Ugo ^a   Nykjaer, Anders ^b   Nielsen, Morten ^b   Soria, Marco R ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

cytotoxicity; internalization; ribosome inactivating protein; saporin; 2 macroglobulin receptor

Indexed keywords

ALPHA 2 MACROGLOBULIN; IMMUNOGLOBULIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; RICIN; RIP PROTEIN, SAPONARIA OFFICINALIS; VEGETABLE PROTEIN; RIBOSOME INACTIVATING PROTEIN; RICIN A; SAPORIN;

ARTICLE; CELL CULTURE; CELL DEATH; DRUG EFFECT; HUMAN; METABOLISM; RADIOASSAY; RIBOSOME; CYTOTOXICITY; ENDOCYTOSIS; HUMAN CELL; PLANT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT;

ALPHA-MACROGLOBULINS; CELL DEATH; HUMAN; LDL-RECEPTOR RELATED PROTEIN 1; PLANT PROTEINS; RADIOLIGAND ASSAY; RECEPTORS, IMMUNOLOGIC; RIBOSOMES; RICIN; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0028977913     PISSN: 00142956     EISSN: 14321033     Source Type: Journal    
DOI: 10.1111/j.1432-1033.1995.tb20795.x     Document Type: Article

References (63)

1. Selective killing of CD4+ and CD8+ cells by immunotoxins containing saporin
2. Ribosome‐inactivating proteins from plants: Properties and possible uses
3. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor
4. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor‐related protein
5. Uptake of native and deglycosylated ricin A‐chain immunotoxins by mouse liver parenchymal and non‐parenchymal cells in vitro and in vivo
6. Comparison of the pharmacokinetics and hepatotoxic effects of saporin and ricin A‐chain immunotoxins on murine liver parenchymal cells
7. 2‐macroglobulin, a multifunctional binding protein with targeting characteristics
8. Receptor‐mediated endocytosis of tissue‐type plasminogen activator by low density lipoprotein receptor‐related protein on human hepatoma HepG2 cells
9. Rationale for clinical use of immunotoxins in cancer and autoimmune disease
10. The role of plasmino‐gen‐activator inhibitor type 1 in the clearance of tissue‐type plasminogen activator by rat hepatoma cells
11. A conjugate between human urokinase and saporin, a type 1 ribosome‐inactivating protein, is selectively cytotoxic in urokinase receptor‐expressing cells
12. Targeting of cytotoxic conjugates to Kaposi's sarcoma‐derived cells
13. 2‐macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase
14. 2‐macroglobulin enhances antibody formation
15. 2‐macroglobulin enhances presentation to T cells
16. 2‐macroglobulin in human U937 cells
17. 2‐macroglobulin receptor
18. The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28 S ribosomal RNA caused by the toxins
19. The site of action of six different ribosome‐inactivating proteins from plants on eukaryotic ribosomes: the RNA N‐glycosidase activity of the proteins
20. Response of refractory Hodgkin's disease to monoclonal anti‐CD30 immunotoxin
21. 2 antibodies for delivering saporin to lymphoma in vitro and in vivo
22. Isoelectric focusing in immobilized pH gradients in the pH 10–11 range
23. 2‐macroglobulin to deglycosylated ricin A chain and its immunotoxins
24. 2MR/LRP). Binding and endocytosis of fluid phase and membrane‐associated ligands
25. Antibody formation against the cytotoxic proteins abrin and ricin in humans and mice
26. The specific cytotoxicity of immunoconjugates containing blocked ricin is dependent on the residual binding capacity of blocked ricin: evidence that the membrane binding and A‐chain translocation activities of ricin cannot be separated
27. Determinants of binding and internalization of tissue‐type plasminogen activator by human vascular smooth muscle and endothelial cells
28. LDL receptor‐related protein internalizes and degrades uPA‐PAI‐1 complexes and is essential for embryo implantation
29. 2‐macroglobulin
30. 2‐macroglobulin receptor
31. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E‐enriched remnant lipo‐proteins by cultured cells
32. 2‐macroglobulin by the alveolar macrophage α‐macroglobulin protease complex receptor
33. 2‐macroglobulin receptor mediates cellular uptake of pro‐urokinase
34. 2‐macroglobulin receptor/low density lipoprotein receptor‐related protein binds and internalizes Pseudomonas exotoxin A
35. Opposing effects of apolipoproteins E and C on lipoprotein binding to low density lipoprotein receptor‐related protein
36. 2‐macroglobulin receptor
37. Mitotoxins: growth factor‐targeted cytotoxic molecules
38. 2‐macroglobulin and regeneration of protease activity and cytotoxicity
39. 2‐macroglobulin receptor and epithelial glycoprotein‐330: two giant receptors mediating endocytosis of multiple ligands
40. 2‐macroglobulin/proteinase complex is achieved by binding to adjacent receptors
41. 2‐macroglobulin receptor/low density lipoprotein receptor‐related protein in human tissues
42. 2‐macroglobulin receptor/low density lipoprotein receptor‐related protein binds lipoprotein lipase and β‐migrating very low density lipoprotein associated with the lipase
43. 2‐macroglobulin receptor/LDL receptor‐related protein involves multiple independent contacts between ligands and receptor. Evidence that the urokinase receptor protects pro‐urokinase against binding to the endocytic receptor
44. 2‐macroglobulin receptor/LDL receptor‐related protein. Evidence for multiple independent contacts between the ligands and receptor
45. A carboxyl‐terminal fragment of lipoprotein lipase binds to the low density lipoprotein receptor‐related protein and inhibits lipase‐mediated uptake of lipoprotein in cells
46. Identification and characterization of urokinase receptors in natural killer cells and T‐cell‐derived lymphokine activated killer cells
47. 2‐macroglobulin receptor/LDL receptor‐related protein binds urokinase‐plasminogen‐activator inhibitor type‐1 complex
48. Expression of ricin A chain in E. coli
49. 2‐macroglobulin receptor
50. 2‐macroglobulin‐trypsin complex to human monocytes in culture
51. Synthesis and characterization of an antihuman T‐lymphocyte saporin immunotoxin (OKT1‐SAP) with in vivo stability into nonhuman primates
52. Ribosome‐inactivating proteins up to date
53. Ribosome inactivating proteins from plants: present status and future prospects
54. Ribosome‐inactivating proteins from the seeds of Saponaria officinalis L. (soapwort), of Agrostemma githago L. (corn cockle) and of Asparagus officinalis L. (asparagus), and from the latex of Hura crepitans L. (sandbox tree)
55. Autocrine saturation of pro‐urokinase receptors on human A431 cells
56. Ligand passing: the 75‐kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55‐kDa TNF receptor
57. BerH2(Anti‐CD30)‐Saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation
58. BB‐10 (AntiCD25)‐saporin immunotoxin: a possible tool in graft versus host disease treatment
59. Addition of an endoplasmic reticulum retrieval sequence to ricin A chain significantly increases its cytotoxicity to mammalian cells
60. 2‐macroglobulin receptor/low density lipoprotein receptor‐related protein. Multiple regulatory sites for 39‐kDa receptor‐associated protein
61. Low density lipoprotein receptor‐related protein and gp330 bind similar ligands, including plasminogen activator‐inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance
62. 2‐macroglobulin endocytosis and degradation in mutant and wild‐type Chinese hamster ovary cells
63. Trichosanthin, alpha‐momorcharin and beta‐momorcharin: identity of abortifacient and ribosome‐inactivating proteins